MedTrace Logo

Enteroprotein Modified Fast ( EMF )

NCT01538654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2017-10-27

No results posted yet for this study

Summary

The purposes of the esperience is:

1. to verify the safety of protein sparing modified fast(PSMF) by enteral route ( EMF )performed in cycles of ten days/months for six months
2. to compare EMF with oral PSMF clinically ( appetite control, fat freemass mantainance, polmonary function tests and metabolic pattern)
3. to verify the weight mantainance after 6 months from the treatment suspension

Conditions

Interventions

PROCEDURE

enteral protein tube feeding in obese

The intervention is represented by a new alternative to treat obese patients by means of a protein sparing modified fast administered by continous 24 h enteral feeding

Sponsors & Collaborators

  • Nestlé Foundation

    collaborator OTHER

  • M.D. Samir G. Sukkar

    lead OTHER

Principal Investigators

  • Samir G Sukkar, MD · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-10
Primary Completion
2012-12-20
Completion
2012-12-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538654 on ClinicalTrials.gov